Quick Answer
Amneal Pharmaceuticals, Inc. reported Total Assets of $3.68 billion for fiscal year 2025.
Amneal Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $3.68B | +5.1% |
| 2024 | $3.50B | +0.8% |
| 2023 | $3.47B | -8.6% |
| 2022 | $3.80B | -3.6% |
| 2021 | $3.94B | -1.7% |
| 2020 | $4.01B | +9.3% |
| 2019 | $3.67B | -15.8% |
| 2018 | $4.35B | +224.4% |
| 2017 | $1.34B | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.60B | +4.0% | +5.2% |
| June 30, 2025 | $3.42B | -2.5% | +1.7% |
| March 31, 2025 | $3.37B | -2.6% | -3.9% |
| December 31, 2024 | $3.50B | +0.8% | +1.2% |
| September 30, 2024 | $3.46B | -6.1% | -1.4% |
| June 30, 2024 | $3.51B | -5.2% | +1.5% |
| March 31, 2024 | $3.46B | -4.7% | -0.5% |
| December 31, 2023 | $3.47B | -8.6% | -5.8% |
- Amneal Pharmaceuticals, Inc. showed an increase of +5.1% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Amneal Pharmaceuticals, Inc.’s total assets has grown by 174.1% (from $1.34 billion to $3.68 billion).
- The most recent figure is from Amneal Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: